BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7906963)

  • 1. Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12.
    Rossi AR; Pericle F; Rashleigh S; Janiec J; Djeu JY
    Blood; 1994 Mar; 83(5):1323-8. PubMed ID: 7906963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Preliminary results in children with acute lymphocytic leukemia and neuroblastoma.
    Anderson PM; Bach FH; Ochoa AC
    Cancer Immunol Immunother; 1988; 27(1):82-8. PubMed ID: 3260824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection of the mouse ICAM-1 gene into murine neuroblastoma enhances susceptibility to lysis, reduces in vivo tumorigenicity and decreases ICAM-2-dependent killing.
    Katsanis E; Bausero MA; Xu H; Orchard PJ; Xu Z; McIvor RS; Brian AA; Blazar BR
    Cancer Immunol Immunother; 1994 Feb; 38(2):135-41. PubMed ID: 7905790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal analysis of peripheral blood lymphocytes from three patients with advanced neuroblastoma receiving recombinant interleukin-2 and interferon alpha.
    Prigione I; Facchetti P; Lanino E; Garaventa A; Pistoia V
    Cancer Immunol Immunother; 1993 Jul; 37(1):40-6. PubMed ID: 8513451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-alpha against primary lung cancer targets.
    Yang SC; Owen-Schaub L; Grimm EA; Roth JA
    Cancer Immunol Immunother; 1989; 29(3):193-8. PubMed ID: 2543502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy.
    Komada Y; Zhang SL; Zhou YW; Hanada M; Shibata T; Azuma E; Sakurai M
    Cancer Immunol Immunother; 1992; 35(4):271-6. PubMed ID: 1511462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the lysis of small-cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell-mediated cytotoxicity.
    Lehmann C; Glass B; Zeis M; Schmitz N; Uharek L
    Cancer Immunol Immunother; 1999 Jul; 48(4):209-13. PubMed ID: 10431691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical enhancement of interleukin-2-mediated cytotoxicity against K562 cells by addition of a low dose of methotrexate.
    Nakarai T; Ueno Y; Ueno Y; Koizumi S
    Cancer Immunol Immunother; 1990; 32(1):8-12. PubMed ID: 2149670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12.
    Zoll B; Lefterova P; Csipai M; Finke S; Trojaneck B; Ebert O; Micka B; Roigk K; Fehlinger M; Schmidt-Wolf GD; Huhn D; Schmidt-Wolf IG
    Cancer Immunol Immunother; 1998 Dec; 47(4):221-6. PubMed ID: 9875675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy.
    Neal ZC; Imboden M; Rakhmilevich AL; Kim KM; Hank JA; Surfus J; Dixon JR; Lode HN; Reisfeld RA; Gillies SD; Sondel PM
    Cancer Immunol Immunother; 2004 Jan; 53(1):41-52. PubMed ID: 14504825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of 27-kDa heat-shock protein in MCF-7 breast cancer cells: effects on lymphocyte-mediated killing by natural killer and gamma delta T cells.
    Mahvi DM; Carper SW; Storm FK; Teal SR; Sondel PM
    Cancer Immunol Immunother; 1993 Aug; 37(3):181-6. PubMed ID: 8334681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of natural and interleukin-2-induced tumour-cytolytic activities by the members of a protein family related to beta-thromboglobulin.
    Klein-Struckmeier A; Knüver-Hopf J; Mohr H
    Cancer Immunol Immunother; 1991; 34(3):175-80. PubMed ID: 1836749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A.
    Morioka N; Sze LL; Morton DL; Irie RF
    Cancer Immunol Immunother; 1993 Oct; 37(5):316-22. PubMed ID: 8402735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of host age upon interleukin-2-mediated anti-tumor responses in a murine fibrosarcoma model.
    Ho SP; Kramer KE; Ershler WB
    Cancer Immunol Immunother; 1990; 31(3):146-50. PubMed ID: 2337904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of virus-modified tumor cell extracts, autologous mononuclear cell infusions and interleukin-2 on oncolytic activity of effector cells of patients with advanced ovarian cancer.
    Furukawa K; Lotzová E; Freedman RS; Bowen JB; Edwards CL; Wharton JT
    Cancer Immunol Immunother; 1989; 30(2):126-32. PubMed ID: 2598179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of resting T cells to autologous natural-killer-cell-mediated lysis by phytohemagglutinin.
    Baraz L; Kotler M; Condiotti R; Nagler A
    Cancer Immunol Immunother; 1999 Dec; 48(9):507-16. PubMed ID: 10602888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of established hepatic human neuroblastoma metastases in mice with severe combined immunodeficiency by antibody-targeted interleukin-2.
    Pancook JD; Becker JC; Gillies SD; Reisfeld RA
    Cancer Immunol Immunother; 1996 Feb; 42(2):88-92. PubMed ID: 8620525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs.
    Helfand SC; Soergel SA; MacWilliams PS; Hank JA; Sondel PM
    Cancer Immunol Immunother; 1994 Aug; 39(2):84-92. PubMed ID: 8044833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity.
    Landoni E; Woodcock MG; Barragan G; Casirati G; Cinella V; Stucchi S; Flick LM; Withers TA; Hudson H; Casorati G; Dellabona P; Genovese P; Savoldo B; Metelitsa LS; Dotti G
    Nat Commun; 2024 Jan; 15(1):89. PubMed ID: 38167707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological effects of IL-21 on immune cells and its potential for cancer treatment.
    Ma M; Xie Y; Liu J; Wu L; Liu Y; Qin X
    Int Immunopharmacol; 2024 Jan; 126():111154. PubMed ID: 37977064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.